Chemoinformaics analysis of (3beta,16alpha)-13,28-Epoxyoleanane-3,16-diol
| Molecular Weight | 458.727 | nRot | 0 |
| Heavy Atom Molecular Weight | 408.327 | nRig | 29 |
| Exact Molecular Weight | 458.376 | nRing | 6 |
| Solubility: LogS | -5.563 | nHRing | 1 |
| Solubility: LogP | 5.634 | No. of Aliphatic Rings | 6 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 5 |
| Atoms Count | 83 | No. of Aliphatic Hetero Cycles | 1 |
| No. of Heavy Atom | 33 | No. of Aromatic Carbocycles | 0 |
| nHetero | 3 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 2 | No. Saturated Carbocycles | 5 |
| No. of Hydrogen atom | 50 | No. of Saturated Hetero Cycles | 1 |
| No. of Carbon atom | 30 | No. of Saturated Rings | 6 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 3 | No. of Arom Bond | 0 |
| nHA | 3 | APOL | 85.8456 |
| nHD | 2 | BPOL | 51.8964 |
| QED | 0.444 |
| Synth | 6.128 |
| Natural Product Likeliness | 3.152 |
| NR-PPAR-gamma | 0.458 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Accepted |
| Pgp-inh | 0.297 |
| Pgp-sub | 0 |
| HIA | 0.013 |
| CACO-2 | -5.271 |
| MDCK | 0.0000202 |
| BBB | 0.058 |
| PPB | 0.94811 |
| VDSS | 1.155 |
| FU | 0.0291301 |
| CYP1A2-inh | 0.011 |
| CYP1A2-sub | 0.41 |
| CYP2c19-inh | 0.058 |
| CYP2c19-sub | 0.92 |
| CYP2c9-inh | 0.193 |
| CYP2c9-sub | 0.251 |
| CYP2d6-inh | 0.018 |
| CYP2d6-sub | 0.539 |
| CYP3a4-inh | 0.488 |
| CYP3a4-sub | 0.251 |
| CL | 5.826 |
| T12 | 0.111 |
| hERG | 0.048 |
| Ames | 0.003 |
| ROA | 0.339 |
| SkinSen | 0.508 |
| Carcinogencity | 0.059 |
| EI | 0.222 |
| Respiratory | 0.98 |
| NR-Aromatase | 0.621 |
| Antiviral | No |
| Prediction | 0.671295 |